No abstract available
MeSH terms
-
Coronary Thrombosis / diagnosis
-
Coronary Thrombosis / epidemiology
-
Coronary Thrombosis / mortality
-
Coronary Thrombosis / prevention & control*
-
Diabetes Complications / diagnosis
-
Diabetes Complications / epidemiology
-
Diabetes Complications / mortality
-
Diabetes Complications / prevention & control*
-
Fibrinolytic Agents / adverse effects
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Platelet Aggregation Inhibitors / adverse effects
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Primary Prevention
-
Risk Factors
-
Secondary Prevention
-
Time Factors
-
Treatment Outcome
Substances
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors